|
⚲
|
| Keyboard |
| Odegard Valerie
✚
|
|
|---|---|
| CIK # | 0001832432 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001832432] | |
| 4 | [0001832432] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Odegard Valerie | |
| Odyssey Therapeutics Inc | |
| ARS Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ARS Pharmaceuticals Inc SBTX
Common Stock
|
2022-05-02 | Grant | 45,233 | $0.00 | |
|
ARS Pharmaceuticals Inc SBTX
Stock Option (right to buy) · derivative
|
2022-05-02 | Grant | 90,467 | $0.00 | |
|
ARS Pharmaceuticals Inc SBTX
Common Stock
|
2022-02-01 | Grant | 16,406 | $0.00 | |
|
ARS Pharmaceuticals Inc SBTX
Stock Option (right to buy) · derivative
|
2022-02-01 | Grant | 98,438 | $0.00 | |
|
ARS Pharmaceuticals Inc SBTX
Stock Option (right to buy) · derivative
|
2022-02-01 | Grant | 49,875 | $0.00 | |
|
ARS Pharmaceuticals Inc SBTX
Stock Option (right to buy) · derivative
|
2020-12-03 | Grant | 364,904 | $0.00 |